SAR156597

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

Sanofi

Overview

SAR156597 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 3 tracked IPF clinical trials.

SAR156597 clinical trials

NCT01529853 (Phase 1)NCT02345070 (Phase 2)NCT02921971 (Phase 2)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about SAR156597 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.